Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort

Background: Breast cancers expressing low (1-9%) immunohistochemistry levels of estrogen and progesterone hormone receptors (HR), remain an uncertain category, being considered either as triple negative (TN) breast cancers or HR-positive (HR+) tumors across guidelines or approvals. Methods: ESME is...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Marie Alexandre, Eva Teruel, Florence Dalenc, Thibaut de la Motte Rouge, Etienne Brain, Vincent Massard, Monica Arnedos, Audrey Mailliez, Jean-Marc Ferrero, Thomas Bachelot, Isabelle Desmoulins, Marie-Ange Mouret-Reynier, Christelle Levy, Antony Gonçalves, Anca Berghian, Thierry Petit, Jean-Sébastien Frenel, Anne-Laure Martin, Thomas Grinda, William Jacot
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2026-08-01
Edice:	Breast
Témata:	Metastatic breast cancer Hormone receptor low Real-world data Overall survival
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S0960977626001256
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!